Dystroglycan (DG) is a cell surface glycoprotein that connects extracellular matrix molecules to the intracellular cytoskeleton, functioning as mechanical and signaling axes in various physiological events. Since the ligand binding activity of DG strictly depends on O-mannosyl glycans attached to its extracellular α-DG subunit, aberrant glycosylation causes dystroglycanopathy, a subclass of congenital muscular dystrophy. Accumulating evidence shows that like-acetylglucosaminyltransferase (LARGE), a glycosyltransferase involved in the biosynthesis of a phosphodiester-linked modification on O-mannose, is essential for α-DG to gain the ligand binding activity. We previously reported that human natural killer-1 sulfotransferase (HNK-1ST), which was originally reported as one of the enzymes responsible for HNK-1 glyco-epitope, had an ability to suppress the glycosylation and function of α-DG. In this study, we investigated how HNK-1ST regulates the glycosylation of α-DG using deletion and mutation analyses. We generated an α-DG mutant which has only one threonine residue capable of being modified by LARGE. Focusing on the single post-phosphoryl modification site, we found that HNK-1ST showed an almost complete inhibition of the LARGE-dependent modification and transferred a sulfate group to the phosphodiester-linked moiety on O-mannose.
determined, two rare types of modification attached to O-linked mannose on α-DG have been found to date. An O-mannosyl tetrasaccharide (Siaα2-3Galβ1-4GlcNAcβ1-2Man) was discovered in bovine peripheral nerve α-dystroglycan (Chiba et al. 1997) and was demonstrated to be synthesized by protein O-mannosyltransferase 1 (POMT1), POMT2, and protein O-mannose β-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (Yoshida et al. 2001; Manya et al. 2004 ). The mutations in the genes encoding POMT1/2 and POMGnT1 cause muscular dystrophies with abnormal α-DG glycosylation designated as Walker-Warburg syndrome and muscle-eye-brain disease, respectively (Yoshida et al. 2001; Beltran-Valero de Bernabe et al. 2002; van Reeuwijk et al. 2005) , implicating the importance of the O-mannosyl tetrasaccharide in α-DG function. Another O-mannosyl modification essential for α-DG function is a phosphodiester-linked structure present at the C-6 hydroxyl group of O-mannose (Yoshida-Moriguchi et al. 2010) . Although the enzyme responsible for the phosphorylation of mannose is unknown at present, three known or putative glycosyltranseferases, fukutin, fukutin-related protein (FKRP), and like-acetylglucosaminyltransferase (LARGE) , have been shown to be involved in the assembly of the post-phosphoryl modification (Yoshida-Moriguchi et al. 2010; Kuga et al. 2012) . The mutations in each gene encoding fukutin, FKRP, and LARGE are associated with the pathogenesis of muscular dystrophy (Kobayashi et al. 1998; Brockington et al. 2001; Longman et al. 2003) . It has been recently demonstrated that LARGE is a bifunctional glycosyltranseferase with glucuronyl-and xylosyltransferase activities, synthesizing disaccharide repeats of glucuronic acid (GlcA) and xylose (Xyl) (Inamori et al. 2012) . Furthermore, the post-phosphoryl modification is absent in the myodystrophy mouse (Large myd ) harboring a spontaneous mutation in LARGE (Yoshida-Moriguchi et al. 2010; Inamori et al. 2012) . While the precise functions of fukutin and FKRP including their enzymatic activities remain unclear, their dysfunctions also lead to the disappearance of the post-phosphoryl modification (Beedle et al. 2012; Kuga et al. 2012) .
We previously found that human natural killer-1 sulfotransferase (HNK-1ST) could suppress the glycosylation and function of α-DG by transferring sulfate groups to α-DG (Nakagawa et al. 2012) . HNK-1ST was originally reported as a sulfotransferase involved in the biosynthesis of HNK-1 carbohydrate, a nervous system-specific glyco-epitope attached to the non-reducing end of glycans (Bakker et al. 1997; Ong et al. 1998) . HNK-1 carbohydrate displays spatiotemporally regulated expression patterns and is carried by limited kinds of glycoproteins such as immunoglobulin-superfamily adhesion molecules (e.g. NCAM, L1, and P0) and several extracellular proteins (e.g. tenascin-C and phosphacan) or glycolipids (Kizuka and Oka 2012) . In general, HNK-1ST acts in combination with one of two responsible glucuronyltransferases (GlcAT-P or GlcAT-S) to synthesize HNK-1 carbohydrate and contributes to the regulation of neural functions (Senn et al. 2002; Yamamoto et al. 2002; Kizuka et al. 2006; Morita et al. 2009 ). In contrast, the α-DG-regulating function of HNK-1ST
does not require either glucuronyltransferase and is independent of HNK-1 biosynthesis (Nakagawa et al. 2012) . However, further information about its precise mode of action, including the specific site of α-DG at which the sulfate group is modified, has yet to be provided.
In the present study, using deletion and mutation analyses, we investigated the mechanism of HNK-1ST-mediated suppression of α-DG glycosylation. Analyzing an α-DG mutant which has a single modification site for LARGE, we found that HNK-1ST almost completely inhibited the LARGE-dependent modification by transferring a sulfate group to the phosphodiester-linked structure on O-mannose. Furthermore, we showed that α-DG pre-sulfated by HNK-1ST was no longer employed as an acceptor substrate by LARGE using an in vitro enzyme assay system. Our findings shed light on the molecular mechanisms underlying the functional diversity of HNK-1ST as well as the elaborately regulated glycosylation of α-DG.
Results

Deletion and mutation analyses reveal the characteristic expression of laminin-binding glycans at distinct sites on α-DG
Since laminin-binding glycans are expressed on the central region of α-DG, called the mucin-like domain (Gln313 to Ser485 in human α-DG) (Barresi and Campbell 2006) , we speculated that HNK-1ST transfers sulfate groups to this domain. To determine the specific sites on α-DG where HNK-1ST-dependent sulfation takes place, we employed a deletion analysis of the mucin-like domain of α-DG. Using a construct encoding α-DG fused to a human IgG Fc fragment (α-DG-Fc), we generated two deletion mutants by utilizing restriction sites in α-DG and termed them Δmucin1-Fc and Δmucin2-Fc, which lack Arg311 through Ile370 and
Val368 through Arg461, respectively ( Figure 1A ). These constructs were transfected in CHO-K1 cells, and the expressed proteins were collected from culture medium by protein G Sepharose-beads and analyzed by Western blotting. The immunoblot with anti-Fc antibody showed that the two deletion mutants were properly expressed ( Figure 1B ). Compared to the full length α-DG-Fc, the molecular weight of Δmucin2-Fc was decreased due to the deleted amino acids, while that of Δmucin1-Fc was increased due to the presence of N-terminal domain resulting from the disruption of the recognition motif RXRR (Arg309 to Arg312) for the proprotein convertase furin (Kanagawa et al. 2004; Singh et al. 2004) . We then assessed the ligand binding activity and glycosylation state of these mutants by the laminin overlay assay and immunoblotting with IIH6 monoclonal antibody, which recognizes the functionally glycosylated form of α-DG (Ervasti and Campbell 1993) . When expressed alone, α-DG-Fc and Δmucin2-Fc but not Δmucin1-Fc exhibited laminin-binding activity, but these laminin-binding moieties were hardly detected by IIH6 antibody ( Figure 1B ). In contrast, co-expression with myc-and His-tagged LARGE (LARGE-myc) resulted in the production of the high-molecular laminin-binding form that could react with IIH6 antibody not only in α-DG-Fc and Δmucin2-Fc but also in Δmucin1-Fc ( Figure 1B ). To determine whether or not the laminin-binding activity produced on Δmucin1-Fc by LARGE overexpression was derived from the post-phosphoryl modification, we employed cold aqueous hydrofluoric acid (HFaq) treatment, which specifically hydrolyzes phosphoester linkages (Yoshida-Moriguchi et al. 2010; Zhang et al. 2012) . As a result, the LARGE-induced laminin-binding activity of Δmucin1-Fc almost disappeared in the HFaq-treated membrane as in the case of α-DG-Fc and Δmucin2-Fc (Supplementary data, Figure S1A ). Regarding the reaction specificity of HFaq treatment, we confirmed that other glyco-epitope, HNK-1, did not disappear by this treatment (Supplementary data, Figure S1B and C). These results suggest that Δmucin1-Fc has at least one potential post-phosphoryl glycosylation site, which LARGE could act on. Similarly, the laminin-binding activities detected on the solely expressed α-DG-Fc and Δmucin2-Fc disappeared by HFaq treatment ( Figure 1C ), indicating that α-DG-Fc and Δmucin2-Fc are modified by the post-phosphoryl modification in CHO-K1 cells, presumably due to the action of endogenous LARGE. Therefore, our findings that the laminin-binding activity was not detected in Δmucin1-Fc without LARGE overexpression although Δmucin1-Fc had potential site(s) for LARGE, suggest a small number of LARGE-dependent modification sites in Δmucin1-Fc.
Previous studies have shown that the first half (Gln313 to Pro408) of the mucin-like domain is sufficient for the ligand binding activity of α-DG and that the second half (Gly409 to Ser485) does not undergo the modification of laminin-binding glycans even in LARGE-overexpressing cells (Kanagawa et al. 2004 ). Thus, considering that Δmucin1-Fc was glycosylated by LARGE, the region between Arg371 and Pro408 is predicted to contain at least one site for the LARGE-dependent glycosylation. While the amino acid sequence from Arg371 to Pro408 contains nine potential O-glycosylation sites including eight Thr and one Ser residues, the specific threonine, Thr379, is reported to bear 6-phosphorylated O-mannose that could be further modified by LARGE (Yoshida-Moriguchi et al. 2010) . Therefore, to confirm whether Thr379 is modified by LARGE, we generated α-DG constructs that harbored a mutation of Thr379 to Ala using α-DG-Fc and Δmucin1-Fc as templates and termed them α-DG-T379A and Δm1-T379A, respectively ( Figure 2A ). When expressed with LARGE-myc in CHO-K1 cells, Δm1-T379A was found to be hardly modified by IIH6-positive laminin-binding glycans ( Figure   2B ). In contrast, T379A mutation on the wild-type α-DG-Fc (α-DG-T379A) caused only slight reductions in laminin-binding and IIH6 immunoreactivity ( Figure 2B ). These results showed that Thr379 was indeed glycosylated by LARGE and was a major modification site within the mucin-like domain of Δmucin1-Fc (Arg371 to Ser485).
HNK-1ST almost entirely inhibits the laminin-binding glycan synthesis by LARGE
We recently revealed that HNK-1ST could counteract the effect of LARGE, resulting in the reduction of α-DG function (Nakagawa et al. 2012) . However, we could not propose mechanistic insights about the α-DG-modulating effect of HNK-1ST including the specific site where the sulfate group is attached. To address this issue, we utilized Δmucin1-Fc to investigate the functional interaction between HNK-1ST and LARGE since it has only one major LARGE modification site. In the presence of HNK-1ST-EGFP, the IIH6-positive laminin-binding glycans generated by LARGE on Δmucin1-Fc as well as the full length α-DG-Fc were markedly suppressed ( Figure 3 ). However, the apparent inhibitory effect of HNK-1ST on the full length α-DG-Fc was somewhat mild considering its residual laminin-binding, whereas that on Δmucin1-Fc was much more drastic because of the almost complete disappearance of its laminin-binding ( Figure 3 ). This difference in degree of the suppressive effect of HNK-1ST was presumably due to the numbers of potential modification sites present in α-DG-Fc and Δmucin1-Fc. The result that HNK-1ST showed almost complete inhibition of the LARGE-dependent glycosylation on Δmucin1-Fc, which had a single LARGE modification site, suggests that HNK-1ST functions in the same glycosylation pathway as LARGE.
HNK-1ST transfers a sulfate group downstream of the phosphodiester linkage of O-mannose
To examine whether HNK-1ST transfers a sulfate group to the post-phosphoryl modification site upon which LARGE acts, resulting in the direct inhibition of the laminin-binding glycan attachment, we carried out a radiolabeled 35 S-sulfate group incorporation assay. As a result, incorporation of 35 S-sulfate groups was detected on Δmucin1-Fc in the presence of HNK-1ST-EGFP ( Figure 4A ). By contrast, Δm1-T379A co-expressed with HNK-1ST-EGFP showed a remarkably decreased 35 S signal compared to Δmucin1-Fc, demonstrating that HNK-1ST mainly transfers a sulfate group onto the glycan modified on Thr379 ( Figure 4A Figure 4B ). As shown in Figure S1A and Figure 2B , LARGE generates a laminin-binding glycan via the phosphodiester linkage at Thr379. Taken together, these findings indicate that both HNK-1ST and LARGE are involved in the post-phosphoryl modification on the specific threonine residue but they have opposite effects on the functional maturation of α-DG.
Pre-sulfated α-DG no longer undergoes glycosylation by LARGE in vitro
To investigate whether the sulfate modification on α-DG is sufficient for impeding the enzymatic reaction of LARGE, we employed an in vitro assay system to assess whether the sulfated α-DG is utilized as a substrate for LARGE. The assay system for LARGE enzymatic activity, the polymerization of GlcA and Xyl, was constructed according to a recently established method (Inamori et al. 2012) , with the full length LARGE-myc proteins used as enzyme sources instead of a secreted form of LARGE. As acceptor substrates, sulfated or non-sulfated Δmucin1-Fc proteins were prepared from Δmucin1-Fc expressing cells with or without co-transfection of HNK-1ST-EGFP. The polymerization reactions of LARGE toward these substrates were then assessed by incubation with LARGE-myc protein, which had been independently prepared from LARGE-myc expressing cells using Ni-NTA conjugated beads.
The reaction products were subjected to Western blotting to evaluate whether the Δmucin1-Fc substrates were modified by laminin-binding glycans. Using the non-sulfated Δmucin1-Fc as a substrate (Δmucin1-Fc), laminin-binding glycans were observed only in the presence of the donor substrates, UDP-GlcA and UDP-Xyl, indicating that LARGE generates the repeating unit of GlcA and Xyl on Δmucin1-Fc, which confers laminin-binding activity ( Figure 5 ). However, in the case of the sulfated Δmucin1-Fc (Δm1+HNK-1ST), laminin-binding glycans were hardly detected on the reaction products, as was the case for Δm1-T379A that lacked the LARGE modification site ( Figure 5 ). These results suggest that the sulfate group on α-DG transferred by HNK-1ST interrupts the sugar polymerization by LARGE probably due to the disruption of the acceptor structure required for the LARGE enzymatic reaction.
Discussion
Accumulating evidence indicates that the post-phosphoryl modification extended from O-linked mannose on α-DG plays a pivotal role in the α-DG-ligand interaction (Yoshida-Moriguchi et al. 2010; Beedle et al. 2012; Inamori et al. 2012; Kuga et al. 2012) . In agreement with this notion, the post-phosphoryl modification is lacking and the free phosphate group is exposed on the O-linked mannose in the tissue preparation from dystroglycanopathy patients and animal models with abnormal glycosylation of α-DG (Yoshida-Moriguchi et al. 2010; Beedle et al. 2012; Kuga et al. 2012) . In this study, using an α-DG deletion mutant (Δmucin1-Fc) and its point mutant, we demonstrated that HNK-1ST transfers a sulfate group downstream of the phosphodiester linkage of O-mannose attached on the specific threonine residue where the laminin-binding glycan is modified. Although we have not yet determined the precise structure of the sulfated glycan generated on α-DG by HNK-1ST, our results revealed that HNK-1ST
functions in the post-phosphoryl modification as in the case of LARGE and negatively regulates the expression of laminin-binding glycans on α-DG.
Since the originally reported enzymatic activity of HNK-1ST is to transfer a sulfate group to the C-3 position of GlcA (Bakker et al. 1997; Ong et al. 1998) (HSO 3 -3GlcAβ1-3Gal) (Schmitz et al. 1994; Tokuda et al. 1998) . Therefore, to address this issue, the structural determination might be the most potent method. Actually, we are trying to determine the sulfated glycan generated on α-DG by HNK-1ST using mass spectrometric analyses. However, at present, we could not detect a glycan structure containing sulfate group(s) in the glycans prepared from the recombinant α-DG-Fc co-expressed with HNK-1ST (data not shown). In addition, we were also not able to detect the phosphate group expected to present on In the deletion analysis of the mucin-like domain of α-DG, we showed that Δmucin2-Fc but not Δmucin1-Fc exhibited laminin-binding activity under conditions without LARGE overexpression and that it was derived from the post-phosphoryl modification ( Figure 1B and   1C ). However, we obtained an apparently contradicting result that Δmucin1-Fc had one site to receive the LARGE-dependent modification ( Figure 2B ). Recently, several LARGE-dependent modification sites were identified in the N-terminal half of the mucin-like domain of α-DG including Thr317 and Thr319, present in a characteristic TPTPV sequence at the N-terminal end of the mucin-like domain (Hara et al. 2011) . Considering that Δmucin2-Fc has multiple modification sites including the TPTPV sequence whereas Δmucin1-Fc has only one site, it might be possible that the presence of the multiple modification sites in the vicinity results in the generation of a cluster of glycans and multivalency, increasing the ligand binding affinity of α-DG. Supporting this idea, clustering of glyco-epitopes has been shown to raise the bioactivities of carrier proteins through increasing the binding affinity to their ligands, such as Tn antigen in tumor progression (Nakada et al. 1993; Matsumoto et al. 2012) and sialyl Lewis X epitope in leukocyte adhesion to endothelial cells (DeFrees et al. 1995; Malý et al. 1996) .
The glycosylation pattern of α-DG varies in a tissue specific-manner (Barresi and Campbell 2006; Beedle et al. 2012; Kuga et al. 2012) . Judging from previous reports, highly glycosylated forms are observed in the skeletal muscle, heart, and kidney while moderately glycosylated forms are seen in the brain, peripheral nerves, and thymus (Beedle et al. 2012;  wild-type mouse organs including lung and testis lacks the post-phosphoryl modification, exhibiting almost no binding affinity to the known ligands such as laminin and agrin (Kuga et al. 2012 ). These observations indicate that non-laminin-binding α-DG is also physiologically important and might have a different role independent of the receptor function relying on the so-called laminin-binding glycans, particularly in those organs lacking the post-phosphoryl modification. They showed that the known genes involved in the functional maturation of α-DG including POMT1, POMT2, POMGnT1, Large, fukutin, and FKRP were expressed even in organs exhibiting low glycosylation of α-DG, and thereby suggested the presence of unknown regulatory mechanisms for the post-phosphoryl modification, such as novel genes or negative regulators (Kuga et al. 2012) . The tissue distribution of HNK-1 carbohydrate is restricted mainly to the brain and peripheral nerves because the expression of the glucuronyltransferases (GlcAT-P and GlcAT-S) is highly limited (Terayama et al. 1997; Seiki et al. 1999; Kizuka and Oka 2012) . However, HNK-1ST is expressed in a wide range of organs (Ong et al. 1998; Tagawa et al. 2005) , indicating the presence of a different function of HNK-1ST, which would be independent of HNK-1 biosynthesis. According to the previous reports, expression sites of HNK-1ST and LARGE are overlapping in several human tissues, such as brain, skeletal muscle, testis, and spleen (Ong et al. 1998; Fujimura et al. 2005) . In addition, the subcellular localizations of both proteins are also overlapping in the Golgi apparatus (Supplementary data, Figure S3 ). Thus, our present results raise the possibility that HNK-1ST is involved in the regulation of α-DG function by suppressing the post-phosphoryl modification via antagonizing LARGE activity, especially in the organs with low glycosylation levels of α-DG. Further investigation is required to understand how HNK-1ST contributes to the functional regulation of α-DG under physiological conditions. In conclusion, our findings illustrate that a single glycosyltransferase has diverse roles that affect different glycan syntheses, implying that the glycosylation system is organized by more complicated mechanisms than previously thought. anti-laminin pAb (Sigma); HNK-1 mAb (a hybridoma cell line was purchased from American Type Culture Collection). For the laminin overlay assay, nitrocellulose membranes with transferred proteins were blocked by the incubation with 5% nonfat dry milk in laminin-binding buffer (LBB; 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl 2 and 1 mM MgCl 2 ,). After being washed in LBB, the membranes were incubated with 1 µg/ml laminin-1 (Sigma) diluted with LBB containing 3% bovine serum albumin (BSA). Bound laminin-1 was detected using anti-laminin antibody by immunoblotting as described above.
Treatment with cold aqueous hydrofluoric acid
To cleave phosphoester linkages, aqueous hydrofluoric acid (HFaq) treatment was performed as follows, according to Zhang et al. (Zhang et al. 2012) with slight modification. After SDS-PAGE, proteins were transferred onto PVDF membranes. The membranes were incubated with ice-cold 48% HFaq (Wako) at 4°C for 16 h. Control samples were prepared similarly and treated with ice-cold water instead. The membranes were then washed with ice-cold water three times to remove residual HF and subjected to laminin overlay assay or immunoblotting.
Radioactive metabolic labeling
CHO-K1 cells were grown overnight in 25 cm 2 cell culture flasks under normal conditions as described above. At 5 h post-transfection, the culture medium was replaced with sulfate-free M8028 MEM (Sigma), and incubation was continued for 1 h. Cells were then labeled with 30 µCi/ml of [ 35 S]-sodium sulfate (ARC Inc.). The culture medium was collected after two nights of labeling and incubated with protein G Sepharose (GE Healthcare) for 2 h. Bound proteins were eluted with Laemmli sample buffer, separated by SDS-PAGE, transferred to nitrocellulose membranes, and then subjected to autoradiography or Western blotting using anti-Fc pAb.
In vitro assay for LARGE polymerization activity
LARGE-myc plasmid was transiently transfected in COS-1 cells using Lipofectamine 2000
with standard protocols. At 48 h post-transfection, the cells were lysed with Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.4, 150 mM NaCl) containing 1% Triton X-100 and protease inhibitor mixture (Nakalai Tesque), and then the cell extracts were obtained by centrifugation.
The cell extracts were diluted to 5-fold volume with TBS and incubated with Ni-NTA conjugated beads (Qiagen) at 4°C for 2h. The protein-bound beads were thoroughly washed with 20 mM phosphate buffer (pH 7.4) containing 300 mM NaCl and 20 mM imidazole. (A) α-DG-Fc, Δmucin1-Fc, and Δmucin2-Fc were transiently transfected with LARGE-myc in CHO-K1 cells. α-DG-Fc and deletion mutants were collected from the culture media, subjected to SDS-PAGE, blotted on the membrane, and treated with cold HFaq (HFaq). A water-treated membrane was prepared as a control (control). The effect of the HFaq treatment on the laminin-binding activity was evaluated by laminin overlay assay. Protein loading was monitored by Western blotting with anti-Fc pAb. (B, C) Membrane fractions of two-week-old mouse brain were subjected to SDS-PAGE, transferred on the PVDF membrane, and then treated by cold HFaq (HFaq). As a control, similarly prepared membranes were treated with water (control). The effect of the HFaq treatment on the laminin-binding activity of brain α-DG was examined by laminin overlay assay (B). Equal protein loading was confirmed by immunoblotting for β-DG. The effect of the HFaq treatment on the HNK-1 carbohydrate was examined by immunoblotting with HNK-1 mAb (C). Note that the laminin-binding disappeared while the HNK-1 immunoreactivity remained in the HFaq-treated half of the blotted membrane. Figure S2 . Absence of the HNK-1-immunoreactivity on α-DG co-expressed with HNK-1ST. α-DG-Fc was transiently co-transfected with HNK-1ST-EGFP in CHO-K1 cells. α-DG-Fc was collected from the culture medium, subjected to SDS-PAGE, and followed by Western blotting using the HNK-1 antibody (medium). An empty vector (pEF-Fc) was transfected as a negative control (mock). Protein loading was monitored by Western blotting with anti-Fc pAb. Membrane fractions of two-week-old mouse brain were loaded as a positive control for the HNK-1-immunoreactivity (2w brain). The expression of HNK-1ST-EGFP was confirmed by Western blotting of CHO-K1 lysates using anti-EGFP antibody (cell lysate). Note that the HNK-1-immunoreactivity was not detected on α-DG-Fc even when co-transfected with HNK-1ST-EGFP. COS-1 cells were transiently expressed with HNK-1ST-EGFP, LARGE-myc/His, or both. At 24 h posttransfection, cells were washed with PBS and fixed with 4% paraformaldehyde. To permeabilize the plasma membrane, cells were incubated with PBS containing 3% BSA and 0.1% Triton X-100. Then, cells were incubated with primary antibodies followed by Alexa Fluor 546 or 488-conjugated secondary antibodies diluted in PBS containing 3% BSA. Cells were counterstained with DAPI to label nuclei. The antibody against GM130 was used to visualize the Golgi apparatus. Scale bar, 20 µm.
anti-Fc
Δmucin1
